Showing 3261-3270 of 6035 results for "".
- Compact Imaging Collaborates with Novartis to Accelerate Development of Home Monitor for AMD and DRhttps://modernod.com/news/compact-imaging-collaborates-with-novartis-to-accelerate-development-of-home-monitor-for-amd-and-dr/2479735/Compact Imaging (CI), a developer of miniaturized optical coherence tomography (OCT) devices, announced the signing of a collaboration agreement with Novartis Pharma under which Novartis will fund Compact Imaging’s development of a low-cost home-based monitor to detect disease progression in adva
- EyeMD EMR Healthcare Systems to Debut its EyeMD Electronic Medical Records 2.0 Releasehttps://modernod.com/news/eyemd-to-debut-its-eyemd-electronic-medical-records-2-0-release/2479739/EyeMD EMR Healthcare Systems, a provider of electronic medical records software designed specifically for ophthalmologists, announced the debut of EyeMD EMR 2.0 at the 2018 American Academy of Ophthalmology’s Annual Meeting in Chicago. “EyeMD EMR 2.0 is the result of years of research and
- LumiThera and Optos Announce Collaboration to Commercialize the Valeda Light Delivery System for Treating Dry AMD in Europehttps://modernod.com/news/lumithera-and-optos-announce-collaboration-to-commercialize-the-valeda-light-delivery-system-for-treating-dry-amd-in-europe/2479740/LumiThera announced a distribution agreement with Optos to exclusively distribute the Valeda Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in 12 European countries. The announcement follows the recent CE Mark certification for the European Union (EU) for th
- Foundation Fighting Blindness Launches Retinal Degeneration Fundhttps://modernod.com/news/foundation-fighting-blindness-launches-retinal-degeneration-fund/2479747/The Foundation Fighting Blindness announced the creation of the first Retinal Degeneration Fund (RD Fund), a wholly owned, 501(c)(3) not-for-profit subsidiary focused on making venture philanthropy investments to furt
- Optos and Amydis Establish Clinical Alliance to Develop Early Diagnostic Test for Alzheimer’s Diseasehttps://modernod.com/news/optos-and-amydis-establish-clinical-alliance-to-develop-early-diagnostic-test-for-alzheimers-disease/2479754/Optos, a subsidiary of Nikon Corporation, and Amydis announced a clinical alliance focused on the development of an eye test by Amydis to detect Alzheimer’s disease. Amydis has developed a pipeline of compounds to detect amyloid proteins in the retina to be visualized with Optos’ optomap ultra-wi
- Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgeryhttps://modernod.com/news/alcon-to-develop-smart-suite-digital-health-platform-for-cataract-surgery/2479762/Alcon announced plans to develop the SMART Suite by Alcon, a digital platform that is designed to streamline, simplify, and improve cataract surgery for surgeons and patients. The SMART Suite by Alcon will connect multiple diagnostic and surgical devices through a digital, open cloud-based
- Hoya Surgical Optics to Acquire Ophthalmic Medical Device Companies Mid Labs, Fritz Ruckhttps://modernod.com/news/hoya-surgical-optics-to-acquire-ophthalmic-medical-device-companies-mid-labs-fritz-ruck/2479775/Hoya Surgical Optics announced that it has entered into a definitive agreement to acquire two medical device companies: US-based Mid Labs and Germany-based Fritz Ruck. Mid Labs is a California-based company focused on the research, innovation, development, engineering, and manufacturin
- Increasing Surgery Volume Will Fuel Single-Use Ophthalmic Surgical Device Markethttps://modernod.com/news/increasing-surgery-volume-will-fuel-single-use-ophthalmic-surgical-device-market/2479784/According to Market Scope research, two factors will drive healthy growth in the single-use ophthalmic surgical product market over the next 5 years: an aging world population, which will lead to steady growth in ophthalmic surgeries, and rising concerns over cross-contamination. Market Sc
- Novaliq Raises New Capital to Accelerate the Commercialization of its Lead Products for Dry Eye Diseasehttps://modernod.com/news/novaliq-raises-new-capital-to-accelerate-the-commercialization-of-its-lead-products-for-dry-eye-disease/2479793/Novaliq announced it has raised $53 million to further support its late-stage products and earlier pipeline programs. Since inception, Novaliq has raised $115 million. The new investment is done by its lead investor dievini Hopp BioTech Holding, an active investor in Life and Health Scienc
- In-Clinic Hurdles for AI-Based Diabetic Retinopathy Detectionhttps://modernod.com/news/in-clinic-hurdles-for-ai-based-diabetic-retinopathy-detection/2479810/Researchers found mixed results when they tested an artificial intelligence (AI)‒based system for detecting diabetic retinopathy (DR) in a real-world primary care setting in Midland, Australia, according to a Medscape report. In th